Skip to main content
ConductScienceScienceDex

FY2026 NIH awards · Principal investigators

Urology at University of Pittsburgh

Pittsburgh, PA

Funding
$1.5M
$1,484,003
Awards
3
FY2026 NIH awards in Urology
Principal investigators
4
2 lead a grant here, 2 co-investigators
Department rank
#24
of 41 · Ranking
  • NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
  • These are the awards in the Urology row of the University of Pittsburgh page.

Leads a grant in this department

2 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.

  1. Zhou Wang

    Leads 2 awards · $899,873

    • 5R01DK134580-04Department: NIH department code
      Role of E-Cadherin Down-Regulation in Prostatic Inflammation and Lower Urinary Tract Dysfunction

      Principal investigators: Zhou Wang (contact PI), Naoki Yoshimura

      $525,423
      award amount
    • 5R01CA265897-05Department: NIH department code
      Targeting androgen receptor nuclear localization in prostate cancer

      Principal investigators: Zhou Wang (contact PI), Peter Wipf

      $374,450
      award amount

  2. Bruce L. Jacobs

    Leads 1 award · $584,130

    • 4R37CA262366-05Department: NIH department code
      Centralization of Cancer Care: Implications for Access, Outcomes, and Disparities
      $584,130
      award amount

Co-investigators

Named as principal investigators on these awards, which someone else leads. They may belong to another department or institution: their own, below, comes from the awards they lead.

  • Naoki Yoshimura

    Co-investigator on 5R01DK134580-04, led by Zhou Wang

    From the FY2024 awards this person leads

  • Peter Wipf

    Co-investigator on 5R01CA265897-05, led by Zhou Wang

    Own institution and department: not known. ScienceDex has no NIH award this person leads as contact PI.